| - GRCh37:
- Chr18:29098182-29178638
| TTR, DSG2 | | Arrhythmogenic right ventricular dysplasia 10, Amyloidogenic transthyretin amyloidosis | Uncertain significance (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175076
- GRCh38:
- Chr18:31595113
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Dec 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29178533
- GRCh38:
- Chr18:31598570
| TTR | | Amyloidogenic transthyretin amyloidosis | Uncertain significance (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29171919
- GRCh38:
- Chr18:31591956
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (May 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29171940
- GRCh38:
- Chr18:31591977
| TTR | | Amyloidogenic transthyretin amyloidosis | Uncertain significance (Jun 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175150
- GRCh38:
- Chr18:31595187
| TTR | K90Q | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Apr 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175117
- GRCh38:
- Chr18:31595154
| TTR | T79A | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Apr 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175090
- GRCh38:
- Chr18:31595127
| TTR | S70G | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172908
- GRCh38:
- Chr18:31592945
| TTR | V40A | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172855
- GRCh38:
- Chr18:31592892
| TTR | | Cardiovascular phenotype, Amyloidogenic transthyretin amyloidosis | Likely benign (Feb 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29178515
- GRCh38:
- Chr18:31598552
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Jan 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29178571
- GRCh38:
- Chr18:31598608
| TTR | T126N | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Mar 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172954
- GRCh38:
- Chr18:31592991
| TTR | K55N | Amyloidogenic transthyretin amyloidosis | Pathogenic (Sep 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172937
- GRCh38:
- Chr18:31592974
| TTR | V50L | Amyloidogenic transthyretin amyloidosis | Pathogenic (Jul 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172936
- GRCh38:
- Chr18:31592973
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Apr 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29171928
- GRCh38:
- Chr18:31591965
| TTR | P22fs | Amyloidogenic transthyretin amyloidosis | Uncertain significance (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29171910
- GRCh38:
- Chr18:31591947
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Mar 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29178628
- GRCh38:
- Chr18:31598665
| TTR | P145H | Amyloidogenic transthyretin amyloidosis, not provided | Uncertain significance (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29171900
- GRCh38:
- Chr18:31591937
| TTR | A12V | Amyloidogenic transthyretin amyloidosis | Uncertain significance (Feb 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29178544
- GRCh38:
- Chr18:31598581
| TTR | A117D | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Dec 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172952
- GRCh38:
- Chr18:31592989
| TTR | K55E | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Dec 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172850
- GRCh38:
- Chr18:31592887
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Oct 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175133
- GRCh38:
- Chr18:31595170
| TTR | F84Y | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Jul 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172963
- GRCh38:
- Chr18:31593000
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Jun 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175217
- GRCh38:
- Chr18:31595254
| TTR | E112G | Amyloidogenic transthyretin amyloidosis | Uncertain significance (Jun 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172897
- GRCh38:
- Chr18:31592934
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Jun 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29178602
- GRCh38:
- Chr18:31598639
| TTR | Y136* | Amyloidogenic transthyretin amyloidosis | Uncertain significance (Oct 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175073
- GRCh38:
- Chr18:31595110
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Jan 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29178584
- GRCh38:
- Chr18:31598621
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Oct 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172973
- GRCh38:
- Chr18:31593010
| TTR | E62K | Amyloidogenic transthyretin amyloidosis, not provided | Uncertain significance (Mar 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29178577
- GRCh38:
- Chr18:31598614
| TTR | A128V | not provided, Cardiovascular phenotype, Amyloidogenic transthyretin amyloidosis
| Uncertain significance (Apr 20, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175114
- GRCh38:
- Chr18:31595151
| TTR | L78V | Amyloidogenic transthyretin amyloidosis | Uncertain significance (Dec 10, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr18:29175094
- GRCh38:
- Chr18:31595131
| TTR | E71A | Cardiovascular phenotype, Amyloidogenic transthyretin amyloidosis | Uncertain significance (Jun 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29178561
- GRCh38:
- Chr18:31598598
| TTR | R123G | Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype | Uncertain significance (Jun 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172899
- GRCh38:
- Chr18:31592936
| TTR | L37P | Amyloidogenic transthyretin amyloidosis | Uncertain significance (Sep 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175198
- GRCh38:
- Chr18:31595235
| TTR | P106A | Amyloidogenic transthyretin amyloidosis | Uncertain significance (Jul 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175102-29175103
- GRCh38:
- Chr18:31595139-31595140
| TTR | E74L | Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype | Pathogenic/Likely pathogenic (Oct 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29171886
- GRCh38:
- Chr18:31591923
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Jan 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29173003
- GRCh38:
- Chr18:31593040
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Apr 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29178605
- GRCh38:
- Chr18:31598642
| TTR | | Cardiovascular phenotype, Amyloidogenic transthyretin amyloidosis | Likely benign (Aug 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29173009
- GRCh38:
- Chr18:31593046
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Apr 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172854
- GRCh38:
- Chr18:31592891
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Nov 13, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175073
- GRCh38:
- Chr18:31595110
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Sep 4, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29171946
- GRCh38:
- Chr18:31591983
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29171947
- GRCh38:
- Chr18:31591984
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Nov 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172840
- GRCh38:
- Chr18:31592877
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Nov 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29173004
- GRCh38:
- Chr18:31593041
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Aug 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29173006
- GRCh38:
- Chr18:31593043
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (May 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29178590
- GRCh38:
- Chr18:31598627
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Dec 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175236
- GRCh38:
- Chr18:31595273
| TTR | | Hyperthyroxinemia, dystransthyretinemic, Amyloidogenic transthyretin amyloidosis, Carpal tunnel syndrome 1, Amyloidogenic transthyretin amyloidosis | Likely benign (Oct 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175105
- GRCh38:
- Chr18:31595142
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175210
- GRCh38:
- Chr18:31595247
| TTR | H110D | Cardiovascular phenotype, Amyloidogenic transthyretin amyloidosis | Conflicting interpretations of pathogenicity (Oct 13, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr18:29175103
- GRCh38:
- Chr18:31595140
| TTR | E74A | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172874
- GRCh38:
- Chr18:31592911
| TTR | K29E | Amyloidogenic transthyretin amyloidosis | Uncertain significance (Sep 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175178
- GRCh38:
- Chr18:31595215
| TTR | W99S | Amyloidogenic transthyretin amyloidosis | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172880
- GRCh38:
- Chr18:31592917
| TTR | P31S | Amyloidogenic transthyretin amyloidosis | Uncertain significance (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172878
- GRCh38:
- Chr18:31592915
| TTR | C30Y | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29171930
- GRCh38:
- Chr18:31591967
| TTR | P22L | Cardiovascular phenotype, Amyloidogenic transthyretin amyloidosis | Uncertain significance (Sep 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29171877
- GRCh38:
- Chr18:31591914
| TTR | H4Q | Amyloidogenic transthyretin amyloidosis | Uncertain significance (Aug 4, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172962
- GRCh38:
- Chr18:31592999
| TTR | D58V | Amyloidogenic transthyretin amyloidosis | Pathogenic (Mar 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175088
- GRCh38:
- Chr18:31595125
| TTR | T69I | Amyloidogenic transthyretin amyloidosis | Pathogenic (Aug 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175193
- GRCh38:
- Chr18:31595230
| TTR | I104T | Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype | Pathogenic/Likely pathogenic (Aug 26, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175082
- GRCh38:
- Chr18:31595119
| TTR | | Amyloidogenic transthyretin amyloidosis | Uncertain significance (Oct 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29171902
- GRCh38:
- Chr18:31591939
| TTR | G13R | Carpal tunnel syndrome 1, Amyloidogenic transthyretin amyloidosis, Hyperthyroxinemia, dystransthyretinemic, Amyloidogenic transthyretin amyloidosis | Uncertain significance (Jan 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172940
- GRCh38:
- Chr18:31592977
| TTR | H51N | Amyloidogenic transthyretin amyloidosis, Carpal tunnel syndrome 1, Amyloidogenic transthyretin amyloidosis, Hyperthyroxinemia, dystransthyretinemic | Uncertain significance (Jul 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172913
- GRCh38:
- Chr18:31592950
| TTR | G42S | Amyloidogenic transthyretin amyloidosis | Uncertain significance (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175196
- GRCh38:
- Chr18:31595233
| TTR | S105F | Hyperthyroxinemia, dystransthyretinemic, Carpal tunnel syndrome 1, Amyloidogenic transthyretin amyloidosis, Amyloidogenic transthyretin amyloidosis | Uncertain significance (Jan 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172903
- GRCh38:
- Chr18:31592940
| TTR | D38E | Cardiovascular phenotype, Amyloidogenic transthyretin amyloidosis | Pathogenic (Apr 17, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29178534
- GRCh38:
- Chr18:31598571
| TTR | V114L | Amyloidogenic transthyretin amyloidosis | Uncertain significance (Apr 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172910
- GRCh38:
- Chr18:31592947
| TTR | R41* | Amyloidogenic transthyretin amyloidosis | Uncertain significance (Jul 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172883-29172884
- GRCh38:
- Chr18:31592920-31592921
| TTR | | Amyloidogenic transthyretin amyloidosis | Uncertain significance (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29178619
- GRCh38:
- Chr18:31598656
| TTR | V142A | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29178561
- GRCh38:
- Chr18:31598598
| TTR | R123C | Hereditary ATTR amyloidosis, Amyloidogenic transthyretin amyloidosis, Cardiomyopathy
| Uncertain significance (Sep 24, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172872
- GRCh38:
- Chr18:31592909
| TTR | S28F | not provided, Amyloidogenic transthyretin amyloidosis | Uncertain significance (Sep 10, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175175
- GRCh38:
- Chr18:31595212
| TTR | Y98F | Cardiovascular phenotype, Amyloidogenic transthyretin amyloidosis | Pathogenic/Likely pathogenic (Sep 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172843
- GRCh38:
- Chr18:31592880
| TTR | | Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype, not provided
| Conflicting interpretations of pathogenicity (Sep 3, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr18:29171889
- GRCh38:
- Chr18:31591926
| TTR | | not provided, Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype
| Benign/Likely benign (Feb 3, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29171851
- GRCh38:
- Chr18:31591888
| TTR | | Cardiovascular phenotype, not provided, Amyloidogenic transthyretin amyloidosis, Carpal tunnel syndrome 1, Hyperthyroxinemia, dystransthyretinemic | Conflicting interpretations of pathogenicity (Jul 8, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr18:29175096
- GRCh38:
- Chr18:31595133
| TTR | S72P | Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype | Pathogenic (Aug 17, 2017) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175182
- GRCh38:
- Chr18:31595219
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Dec 25, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29178617
- GRCh38:
- Chr18:31598654
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Oct 16, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29171931
- GRCh38:
- Chr18:31591968
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Jan 29, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175197
- GRCh38:
- Chr18:31595234
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29171905
- GRCh38:
- Chr18:31591942
| TTR | | not provided, Hyperthyroxinemia, dystransthyretinemic, Amyloidogenic transthyretin amyloidosis, Carpal tunnel syndrome 1, Amyloidogenic transthyretin amyloidosis | Benign/Likely benign (May 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29178585
- GRCh38:
- Chr18:31598622
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Dec 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172997
- GRCh38:
- Chr18:31593034
| TTR | | Amyloidogenic transthyretin amyloidosis | Likely benign (Jan 30, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172945
- GRCh38:
- Chr18:31592982
| TTR | | Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype | Likely benign (Jun 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172971
- GRCh38:
- Chr18:31593008
| TTR | W61L | Amyloidogenic transthyretin amyloidosis | Pathogenic (Sep 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172883
- GRCh38:
- Chr18:31592920
| TTR | L32V | Cardiovascular phenotype, Amyloidogenic transthyretin amyloidosis | Pathogenic (Feb 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29178575
- GRCh38:
- Chr18:31598612
| TTR | I127M | Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype | Pathogenic/Likely pathogenic (Jul 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175207
- GRCh38:
- Chr18:31595244
| TTR | E109K | not provided, Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype
| Pathogenic/Likely pathogenic (Sep 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172975
- GRCh38:
- Chr18:31593012
| TTR | E62D | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175133
- GRCh38:
- Chr18:31595170
| TTR | F84S | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29175099
- GRCh38:
- Chr18:31595136
| TTR | G73R | Amyloidogenic transthyretin amyloidosis | Likely pathogenic (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr18:29172968
- GRCh38:
- Chr18:31593005
| TTR | T60N | Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype | Likely pathogenic (Jan 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172974
- GRCh38:
- Chr18:31593011
| TTR | E62A | Amyloidogenic transthyretin amyloidosis | Uncertain significance (Nov 13, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr18:29178635
- GRCh38:
- Chr18:31598672
| TTR | | not provided, Amyloidogenic transthyretin amyloidosis | Likely benign (Oct 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29175223
- GRCh38:
- Chr18:31595260
| TTR | | Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype | Uncertain significance (Oct 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29178555
- GRCh38:
- Chr18:31598592
| TTR | G121S | Hyperthyroxinemia, dystransthyretinemic, Amyloidogenic transthyretin amyloidosis, Carpal tunnel syndrome 1, Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype | Uncertain significance (Jun 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr18:29172993
- GRCh38:
- Chr18:31593030
| TTR | | Amyloidogenic transthyretin amyloidosis | Uncertain significance (Nov 17, 2021) | criteria provided, single submitter |